Cargando…

Case Reports: Transformation of End-Stage Neuroendocrine Tumors With Uncontrollable Liver Metastasis Into a Novel or Additional Functional Phenotype

Background: Neuroendocrine tumors (NETs) are rare, but their worldwide incidence is gradually increasing. NETs are generally heterogeneous; however, in rare cases, they have been shown to change their phenotype (i.e., nonfunctional to functional or one functional phenotype to the addition of another...

Descripción completa

Detalles Bibliográficos
Autores principales: Kessoku, Takaomi, Kobayashi, Noritoshi, Yoneda, Masato, Kasai, Yuki, Ozaki, Anna, Okubo, Naoki, Iwaki, Michihiro, Kobayashi, Takashi, Yoshihara, Tsutomu, Kurita, Yusuke, Honda, Yasushi, Tokuhisa, Motohiko, Ishiki, Hiroto, Hibiya, Takashi, Fujii, Satoshi, Nakajima, Atsushi, Ichikawa, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544986/
https://www.ncbi.nlm.nih.gov/pubmed/33102220
http://dx.doi.org/10.3389/fonc.2020.555963
_version_ 1783591939478650880
author Kessoku, Takaomi
Kobayashi, Noritoshi
Yoneda, Masato
Kasai, Yuki
Ozaki, Anna
Okubo, Naoki
Iwaki, Michihiro
Kobayashi, Takashi
Yoshihara, Tsutomu
Kurita, Yusuke
Honda, Yasushi
Tokuhisa, Motohiko
Ishiki, Hiroto
Hibiya, Takashi
Fujii, Satoshi
Nakajima, Atsushi
Ichikawa, Yasushi
author_facet Kessoku, Takaomi
Kobayashi, Noritoshi
Yoneda, Masato
Kasai, Yuki
Ozaki, Anna
Okubo, Naoki
Iwaki, Michihiro
Kobayashi, Takashi
Yoshihara, Tsutomu
Kurita, Yusuke
Honda, Yasushi
Tokuhisa, Motohiko
Ishiki, Hiroto
Hibiya, Takashi
Fujii, Satoshi
Nakajima, Atsushi
Ichikawa, Yasushi
author_sort Kessoku, Takaomi
collection PubMed
description Background: Neuroendocrine tumors (NETs) are rare, but their worldwide incidence is gradually increasing. NETs are generally heterogeneous; however, in rare cases, they have been shown to change their phenotype (i.e., nonfunctional to functional or one functional phenotype to the addition of another functional phenotype). Here, we present two cases of liver metastatic NETs with phenotype transformation at the advanced stage that led to life-threatening events. Case presentation: A 73-year-old woman had a small intestinal nonfunctional NET with liver metastasis. After uncontrollable liver metastasis at the advanced stage, she developed duodenal perforation with hypergastremia. The patient was treated with octreotide and proton pump inhibitors and underwent endoscopic closure for duodenal perforation, but her general condition gradually deteriorated, and she died 2 weeks after duodenal perforation. Another patient, a 50-year-old man, had a functional NET (gastrinoma) with liver metastasis and duodenal ulcer. After uncontrollable liver metastasis at the advanced stage, he developed hypoglycemia. Although octoreotide and diazoxide were administrated for hyperalimentation, his hypoglycemia was uncontrollable, and he died after 4 months owing to general deterioration. Conclusion: The present cases show that advanced NETs with treatment-uncontrollable liver metastasis can transform their phenotype, specifically from a nonfunctional NET into a functional NET, and from one functional NET into the addition of another functional NET. These experiences suggest that the presence of treatment-resistant liver metastasis might be a hallmark of the potential to gain novel functions.
format Online
Article
Text
id pubmed-7544986
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-75449862020-10-22 Case Reports: Transformation of End-Stage Neuroendocrine Tumors With Uncontrollable Liver Metastasis Into a Novel or Additional Functional Phenotype Kessoku, Takaomi Kobayashi, Noritoshi Yoneda, Masato Kasai, Yuki Ozaki, Anna Okubo, Naoki Iwaki, Michihiro Kobayashi, Takashi Yoshihara, Tsutomu Kurita, Yusuke Honda, Yasushi Tokuhisa, Motohiko Ishiki, Hiroto Hibiya, Takashi Fujii, Satoshi Nakajima, Atsushi Ichikawa, Yasushi Front Oncol Oncology Background: Neuroendocrine tumors (NETs) are rare, but their worldwide incidence is gradually increasing. NETs are generally heterogeneous; however, in rare cases, they have been shown to change their phenotype (i.e., nonfunctional to functional or one functional phenotype to the addition of another functional phenotype). Here, we present two cases of liver metastatic NETs with phenotype transformation at the advanced stage that led to life-threatening events. Case presentation: A 73-year-old woman had a small intestinal nonfunctional NET with liver metastasis. After uncontrollable liver metastasis at the advanced stage, she developed duodenal perforation with hypergastremia. The patient was treated with octreotide and proton pump inhibitors and underwent endoscopic closure for duodenal perforation, but her general condition gradually deteriorated, and she died 2 weeks after duodenal perforation. Another patient, a 50-year-old man, had a functional NET (gastrinoma) with liver metastasis and duodenal ulcer. After uncontrollable liver metastasis at the advanced stage, he developed hypoglycemia. Although octoreotide and diazoxide were administrated for hyperalimentation, his hypoglycemia was uncontrollable, and he died after 4 months owing to general deterioration. Conclusion: The present cases show that advanced NETs with treatment-uncontrollable liver metastasis can transform their phenotype, specifically from a nonfunctional NET into a functional NET, and from one functional NET into the addition of another functional NET. These experiences suggest that the presence of treatment-resistant liver metastasis might be a hallmark of the potential to gain novel functions. Frontiers Media S.A. 2020-09-25 /pmc/articles/PMC7544986/ /pubmed/33102220 http://dx.doi.org/10.3389/fonc.2020.555963 Text en Copyright © 2020 Kessoku, Kobayashi, Yoneda, Kasai, Ozaki, Okubo, Iwaki, Kobayashi, Yoshihara, Kurita, Honda, Tokuhisa, Ishiki, Hibiya, Fujii, Nakajima and Ichikawa. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Kessoku, Takaomi
Kobayashi, Noritoshi
Yoneda, Masato
Kasai, Yuki
Ozaki, Anna
Okubo, Naoki
Iwaki, Michihiro
Kobayashi, Takashi
Yoshihara, Tsutomu
Kurita, Yusuke
Honda, Yasushi
Tokuhisa, Motohiko
Ishiki, Hiroto
Hibiya, Takashi
Fujii, Satoshi
Nakajima, Atsushi
Ichikawa, Yasushi
Case Reports: Transformation of End-Stage Neuroendocrine Tumors With Uncontrollable Liver Metastasis Into a Novel or Additional Functional Phenotype
title Case Reports: Transformation of End-Stage Neuroendocrine Tumors With Uncontrollable Liver Metastasis Into a Novel or Additional Functional Phenotype
title_full Case Reports: Transformation of End-Stage Neuroendocrine Tumors With Uncontrollable Liver Metastasis Into a Novel or Additional Functional Phenotype
title_fullStr Case Reports: Transformation of End-Stage Neuroendocrine Tumors With Uncontrollable Liver Metastasis Into a Novel or Additional Functional Phenotype
title_full_unstemmed Case Reports: Transformation of End-Stage Neuroendocrine Tumors With Uncontrollable Liver Metastasis Into a Novel or Additional Functional Phenotype
title_short Case Reports: Transformation of End-Stage Neuroendocrine Tumors With Uncontrollable Liver Metastasis Into a Novel or Additional Functional Phenotype
title_sort case reports: transformation of end-stage neuroendocrine tumors with uncontrollable liver metastasis into a novel or additional functional phenotype
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544986/
https://www.ncbi.nlm.nih.gov/pubmed/33102220
http://dx.doi.org/10.3389/fonc.2020.555963
work_keys_str_mv AT kessokutakaomi casereportstransformationofendstageneuroendocrinetumorswithuncontrollablelivermetastasisintoanoveloradditionalfunctionalphenotype
AT kobayashinoritoshi casereportstransformationofendstageneuroendocrinetumorswithuncontrollablelivermetastasisintoanoveloradditionalfunctionalphenotype
AT yonedamasato casereportstransformationofendstageneuroendocrinetumorswithuncontrollablelivermetastasisintoanoveloradditionalfunctionalphenotype
AT kasaiyuki casereportstransformationofendstageneuroendocrinetumorswithuncontrollablelivermetastasisintoanoveloradditionalfunctionalphenotype
AT ozakianna casereportstransformationofendstageneuroendocrinetumorswithuncontrollablelivermetastasisintoanoveloradditionalfunctionalphenotype
AT okubonaoki casereportstransformationofendstageneuroendocrinetumorswithuncontrollablelivermetastasisintoanoveloradditionalfunctionalphenotype
AT iwakimichihiro casereportstransformationofendstageneuroendocrinetumorswithuncontrollablelivermetastasisintoanoveloradditionalfunctionalphenotype
AT kobayashitakashi casereportstransformationofendstageneuroendocrinetumorswithuncontrollablelivermetastasisintoanoveloradditionalfunctionalphenotype
AT yoshiharatsutomu casereportstransformationofendstageneuroendocrinetumorswithuncontrollablelivermetastasisintoanoveloradditionalfunctionalphenotype
AT kuritayusuke casereportstransformationofendstageneuroendocrinetumorswithuncontrollablelivermetastasisintoanoveloradditionalfunctionalphenotype
AT hondayasushi casereportstransformationofendstageneuroendocrinetumorswithuncontrollablelivermetastasisintoanoveloradditionalfunctionalphenotype
AT tokuhisamotohiko casereportstransformationofendstageneuroendocrinetumorswithuncontrollablelivermetastasisintoanoveloradditionalfunctionalphenotype
AT ishikihiroto casereportstransformationofendstageneuroendocrinetumorswithuncontrollablelivermetastasisintoanoveloradditionalfunctionalphenotype
AT hibiyatakashi casereportstransformationofendstageneuroendocrinetumorswithuncontrollablelivermetastasisintoanoveloradditionalfunctionalphenotype
AT fujiisatoshi casereportstransformationofendstageneuroendocrinetumorswithuncontrollablelivermetastasisintoanoveloradditionalfunctionalphenotype
AT nakajimaatsushi casereportstransformationofendstageneuroendocrinetumorswithuncontrollablelivermetastasisintoanoveloradditionalfunctionalphenotype
AT ichikawayasushi casereportstransformationofendstageneuroendocrinetumorswithuncontrollablelivermetastasisintoanoveloradditionalfunctionalphenotype